Hyperbaric Chamber for Brain Health: Oxygen, Neuroplasticity & Cognition

The brain consumes roughly 20 percent of the body’s oxygen despite making up only two percent of its weight. This disproportionate oxygen demand means the brain is both exquisitely sensitive to oxygen deficiency and highly responsive to oxygen abundance. Hyperbaric oxygen therapy (HBOT) has long been used for medical emergencies and wound healing, but a newer and growing body of research is exploring something more expansive: whether HBOT can actively support and improve brain function in healthy and aging adults. It is one of several brain conditions where HBOT is being studied currently being explored in clinical research.

What Does the Research Say?

The most rigorous human study to date is a 2020 randomized controlled trial from the Sagol Center for Hyperbaric Medicine in Tel Aviv.¹ The trial enrolled 63 healthy adults aged over 64 and randomized them to 60 daily sessions at 2.0 ATA (100% oxygen, 90 minutes including air breaks) or a control condition. The primary outcome, global cognitive function, showed a significant group-by-time interaction (p=0.0017). Effect sizes for the two most affected domains were large: attention at 0.745 and information processing speed at 0.788. Executive functions also improved significantly.

The same trial used voxel-based MRI perfusion analysis to confirm the mechanism. Significant cerebral blood flow increases were documented in the right superior medial frontal gyrus, supplementary motor areas bilaterally, middle frontal gyrus, superior frontal gyrus, and right superior parietal gyrus. The cognitive improvements were mediated by these regional blood flow changes.¹

Cerebral Blood Flow and Angiogenesis

One of the most consistent findings across brain health research is that HBOT increases cerebral blood flow, not only by delivering dissolved oxygen to plasma, but by stimulating the growth of new blood vessels (angiogenesis). A 2015 retrospective analysis of 10 post-TBI patients who were a mean of 10.3 years post-injury found that 60 HBOT sessions produced significantly increased cerebral blood flow and cerebral blood volume on whole-brain perfusion analysis, with significant cognitive improvement (p=0.007).³ The most prominent improvements were in information processing speed, visual-spatial processing, and motor skills, the same domains that tend to decline earliest with age.

A parallel study in an Alzheimer’s mouse model and elderly patients with significant memory loss found HBOT increased arteriolar luminal diameter, elevated cerebral blood flow, reduced amyloid burden, and improved cognitive performance after 60 sessions.² This suggests HBOT may address multiple pathways of cognitive decline simultaneously.

How HBOT Influences Brain Biology

A 2021 review in Biomolecules synthesized the mechanistic evidence across 102 cited papers.⁴ The key pathways documented include:

• Neuroplasticity induction: HBOT activates transcription factors including HIF-1, VEGF, and SIRT-1 that drive synaptic remodeling and new neural connections
• Angiogenesis: New blood vessel formation in previously hypoperfused brain regions, confirmed on perfusion MRI and SPECT imaging³
• Enhanced mitochondrial function: Improved energy production in neurons, critical for cognitive performance
• Reduced oxidative stress and inflammation: Modulation of inflammatory cytokines and activation of antioxidant systems
• Telomere lengthening and senescent cell clearance: Documented in the same Efrati group research, though awaiting independent replication
• Autophagy activation: A 2024 study in aged mice found HBOT upregulated PSD95, BDNF, and synaptic proteins while activating the AMPK-mTOR autophagy pathway, improving spatial learning in the Morris water maze⁶

What to Expect: Protocols and Realistic Outcomes

The research protocols for brain health generally use 60 sessions at 2.0 ATA (atmospheres absolute), 90 minutes per session, five days per week over 12 weeks. This is the Efrati/Sagol protocol used in the only RCT showing significant cognitive effects in healthy aging adults. Sessions at 1.5 ATA for 40-60 sessions have also been used in cognitive research, though the specific evidence for healthy aging is strongest at 2.0 ATA.¹

Hard chamber facilities are required for these protocols. Soft chambers at 1.3 ATA have not been validated for cognitive enhancement in published research. Most sessions take place in a monoplace (single-person tube) or multiplace chamber. You breathe 100% oxygen through a mask or hood while lying comfortably. Most people read, listen to music, or rest during sessions.

For a broader overview of what sessions look like, visit our HBOT sessions guide. For information on related neurological applications, see our pages on HBOT for brain injury and HBOT for cognitive impairment.

Honest Assessment of Limitations

The evidence for HBOT and general brain health is genuinely interesting but has important caveats. The strongest human data comes almost entirely from a single research group at Tel Aviv University. Independent replication of the cognitive enhancement findings in healthy adults has not yet been published. The 2020 RCT, while well-designed, enrolled only 63 participants and was conducted without a true sham control.

The cognitive domains most improved – attention and information processing speed – are real but not the same as preventing dementia or reversing aging. Results in healthy older adults may not generalize to people with diagnosed cognitive conditions. Protocol variation (pressure, number of sessions, frequency) makes cross-study comparison difficult.

HBOT for general brain health is off-label and not covered by insurance. A 60-session course at a clinical facility typically costs $9,000-$18,000 out of pocket. Anyone considering HBOT for brain health should have a thorough medical evaluation and realistic expectations about what the research currently supports.

Who Should Not Try HBOT

HBOT is generally safe when administered by trained professionals, but it is not appropriate for everyone. Discuss your full medical history with your provider before starting.

Absolute Contraindications

• Untreated pneumothorax (collapsed lung) – pressure changes can worsen this condition and become life-threatening
• Certain chemotherapy drugs – bleomycin, cisplatin, doxorubicin, and disulfiram may interact dangerously with high-oxygen environments

Relative Contraindications

• Upper respiratory infection or sinus congestion – difficulty equalizing pressure can cause ear or sinus barotrauma
• Seizure disorder – high-pressure oxygen can lower seizure threshold in susceptible individuals
• Chronic obstructive pulmonary disease (COPD) – altered breathing drive may require modified protocols
• High fever – increases the risk of oxygen toxicity
• History of ear surgery or chronic ear problems – pressure equalization may be difficult or risky
• Claustrophobia – may require sedation or use of a multiplace chamber instead
• Pregnancy – insufficient safety data exists for routine use during pregnancy

Talk to Your Doctor First

Even if you do not have the conditions listed above, always consult your physician before starting HBOT, especially if you take insulin, have a pacemaker or implanted device, or are currently taking any medications. For a full overview of HBOT side effects and risks, see our detailed guide.

References

1. Hadanny A, Daniel-Kotovsky M, Suzin G, et al. “Cognitive enhancement of healthy older adults using hyperbaric oxygen: a randomized controlled trial.” Aging. 2020;12(13):13740-13761. DOI: 10.18632/aging.103571
2. Shapira R, Gdalyahu A, Gottfried I, et al. “Hyperbaric oxygen therapy alleviates vascular dysfunction and amyloid burden in an Alzheimer’s disease mouse model and in elderly patients.” Aging. 2021;13(16):20935-20969. DOI: 10.18632/aging.203485
3. Tal S, Hadanny A, Berkovitz N, et al. “HBOT may induce angiogenesis in patients suffering from prolonged post-concussion syndrome.” Restorative Neurology and Neuroscience. 2015;33(6):943-951. DOI: 10.3233/RNN-150585
4. Gottfried I, Schottlender N, Ashery U. “Hyperbaric Oxygen Treatment – From Mechanisms to Cognitive Improvement.” Biomolecules. 2021;11(10):1520. DOI: 10.3390/biom11101520
5. Vila JF, Balcarce PE, Abiusi GR, et al. “Improvement in motor and cognitive impairment after HBO in patients with cerebrovascular disease.” Undersea and Hyperbaric Medicine. 2005.
6. Wang S, Chen B, Yuan M, et al. “Enriched oxygen improves age-related cognitive impairment through enhancing autophagy.” Frontiers in Aging Neuroscience. 2024;16:1340117. DOI: 10.3389/fnagi.2024.1340117
7. Hadanny A, et al. “HBOT can induce neuroplasticity and improve cognitive functions in anoxic brain damage.” Restorative Neurology and Neuroscience. 2015;33(6):471-486. DOI: 10.3233/RNN-150517
8. Alashram A, et al. “HBOT for cognitive impairments in patients with TBI: A systematic review.” Applied Neuropsychology: Adult. 2022. DOI: 10.1080/23279095.2022.2041418

Seph Fontane Pennock

Author

Seph Fontane Pennock is the founder of BaricBoost.com and Regenerated.com, a clinic directory for regenerative medicine serving 10,000+ providers across the United States. He previously built and sold PositivePsychology.com, which grew to 19 million users and became the largest evidence-based positive psychology resource on the web. Seph brings direct experience as an HBOT patient, having completed protocols at clinics across three continents while navigating mold illness, systemic inflammation, and autoimmune conditions. His treatment journey includes hyperbaric oxygen therapy, peptide protocols, NAD+ therapy, and consultations with specialists from Dubai to Cape Town to Mexico. This combination of entrepreneurial track record and lived patient experience shapes everything published on BaricBoost.com. Every article is grounded in peer-reviewed research, informed by real clinical encounters, and written for patients making high-stakes treatment decisions. Seph's focus is on bringing transparency, scientific rigor, and practical guidance to the hyperbaric oxygen therapy space.

Website